EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Cancer Chemotherapy and Pharmacology


 

Status
active
Indexing
Current Contents, Index Medicus/MEDLINE
Subject

Source type
Journal
Publisher
ISBN ISSN
0344-5704
E ISSN
1432-0843
First volume
1
Last volume
62+
Publish city
Berlin - Heidelberg
Homepage
Description
Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials.

The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Essential reading for pharmacologists and oncologists.


Related links:









Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )